Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.
Saved in:
| Title: | Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses. |
|---|---|
| Authors: | Mayadev J; Radiation Medicine and Applied Sciences Department, University of California San Diego Medical Center, San Diego, USA. Electronic address: jmayadev@health.ucsd.edu., Vázquez Limón JC; Department of Medical Oncology, Antiguo Hospital Civil de Guadalajara 'Fray Antonio Alcalde', University of Guadalajara, Guadalajara, Mexico., Ramírez Godinez FJ; Department of Medical Oncology, Hospital Civil de Guadalajara, Guadalajara, Mexico., Leiva M; Oncology Medicine, Institute of Oncology and Radiotherapy of the Ricardo Palma Clinic, San Isidro, Peru., Cetina-Pérez LDC; Department of Clinical Research, National Cancer Institute, Mexico City, Mexico., Varga S; National Institute of Oncology, Budapest, Hungary., Molina Alavez A; Centro de atención e Investigación Clínica en Oncología, Mérida, Mexico., Alarcon-Rozas AE; Santa Beatriz Clinic, Lima, Peru., Valdiviezo N; National Institute of Neoplastic Diseases, Lima, Peru., Acevedo C; Cayetano Heredia National Hospital, San Martín de Porres, Peru., Figueroa A; ALIADA, Lima Oncology Center, Lima, Peru., Santini A; Antofagasta Cancer Center, Antofagasta, Chile., Vera L; International Clinic-San Borja, Lima, Peru., Rey F; CIDO Clinic, Temuco, Chile., Kahán Z; Department of Oncotherapy, University of Szeged, Szeged, Hungary., Galaz P; Radio Medicine Institute, Santiago, Chile., Meléndez Mier G; Autonomous University of Nuevo León, San Nicolás de los Garza, Monterrey, Mexico., Wu X; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Mandai M; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan., Shapira-Frommer R; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel., Estevez-Diz MDP; Department of Radiology and Oncology, Instituto do Cancer do Estado de Sao Paulo-Universidade de Sao Paulo, São Paulo, Brazil., Limaye S; Department of Medical Oncology, Sir H N Reliance Foundation Hospital, Mumbai, India., Xin W; Biometrics Late Respiratory Immunology, AstraZeneca, Gothenburg, Sweden., Dry H; Late Development Oncology R&D, AstraZeneca, Waltham, USA., Broggi MAS; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, USA., Yuan DY; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, USA., Stewart RA; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, USA. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Sep; Vol. 36 (9), pp. 1047-1057. Date of Electronic Publication: 2025 Jun 02. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40500687 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mayadev+J%22">Mayadev J</searchLink>; Radiation Medicine and Applied Sciences Department, University of California San Diego Medical Center, San Diego, USA. Electronic address: jmayadev@health.ucsd.edu.<br /><searchLink fieldCode="AU" term="%22Vázquez+Limón+JC%22">Vázquez Limón JC</searchLink>; Department of Medical Oncology, Antiguo Hospital Civil de Guadalajara 'Fray Antonio Alcalde', University of Guadalajara, Guadalajara, Mexico.<br /><searchLink fieldCode="AU" term="%22Ramírez+Godinez+FJ%22">Ramírez Godinez FJ</searchLink>; Department of Medical Oncology, Hospital Civil de Guadalajara, Guadalajara, Mexico.<br /><searchLink fieldCode="AU" term="%22Leiva+M%22">Leiva M</searchLink>; Oncology Medicine, Institute of Oncology and Radiotherapy of the Ricardo Palma Clinic, San Isidro, Peru.<br /><searchLink fieldCode="AU" term="%22Cetina-Pérez+LDC%22">Cetina-Pérez LDC</searchLink>; Department of Clinical Research, National Cancer Institute, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Varga+S%22">Varga S</searchLink>; National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Molina+Alavez+A%22">Molina Alavez A</searchLink>; Centro de atención e Investigación Clínica en Oncología, Mérida, Mexico.<br /><searchLink fieldCode="AU" term="%22Alarcon-Rozas+AE%22">Alarcon-Rozas AE</searchLink>; Santa Beatriz Clinic, Lima, Peru.<br /><searchLink fieldCode="AU" term="%22Valdiviezo+N%22">Valdiviezo N</searchLink>; National Institute of Neoplastic Diseases, Lima, Peru.<br /><searchLink fieldCode="AU" term="%22Acevedo+C%22">Acevedo C</searchLink>; Cayetano Heredia National Hospital, San Martín de Porres, Peru.<br /><searchLink fieldCode="AU" term="%22Figueroa+A%22">Figueroa A</searchLink>; ALIADA, Lima Oncology Center, Lima, Peru.<br /><searchLink fieldCode="AU" term="%22Santini+A%22">Santini A</searchLink>; Antofagasta Cancer Center, Antofagasta, Chile.<br /><searchLink fieldCode="AU" term="%22Vera+L%22">Vera L</searchLink>; International Clinic-San Borja, Lima, Peru.<br /><searchLink fieldCode="AU" term="%22Rey+F%22">Rey F</searchLink>; CIDO Clinic, Temuco, Chile.<br /><searchLink fieldCode="AU" term="%22Kahán+Z%22">Kahán Z</searchLink>; Department of Oncotherapy, University of Szeged, Szeged, Hungary.<br /><searchLink fieldCode="AU" term="%22Galaz+P%22">Galaz P</searchLink>; Radio Medicine Institute, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Meléndez+Mier+G%22">Meléndez Mier G</searchLink>; Autonomous University of Nuevo León, San Nicolás de los Garza, Monterrey, Mexico.<br /><searchLink fieldCode="AU" term="%22Wu+X%22">Wu X</searchLink>; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Mandai+M%22">Mandai M</searchLink>; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Shapira-Frommer+R%22">Shapira-Frommer R</searchLink>; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Estevez-Diz+MDP%22">Estevez-Diz MDP</searchLink>; Department of Radiology and Oncology, Instituto do Cancer do Estado de Sao Paulo-Universidade de Sao Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Limaye+S%22">Limaye S</searchLink>; Department of Medical Oncology, Sir H N Reliance Foundation Hospital, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Xin+W%22">Xin W</searchLink>; Biometrics Late Respiratory Immunology, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Dry+H%22">Dry H</searchLink>; Late Development Oncology R&D, AstraZeneca, Waltham, USA.<br /><searchLink fieldCode="AU" term="%22Broggi+MAS%22">Broggi MAS</searchLink>; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+DY%22">Yuan DY</searchLink>; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+RA%22">Stewart RA</searchLink>; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Monk+BJ%22">Monk BJ</searchLink>; Florida Cancer Specialists and Research Institute, West Palm Beach, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2025 Sep; Vol. 36 (9), pp. 1047-1057. <i>Date of Electronic Publication: </i>2025 Jun 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40500687 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.05.533 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1047 Titles: – TitleFull: Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mayadev J – PersonEntity: Name: NameFull: Vázquez Limón JC – PersonEntity: Name: NameFull: Ramírez Godinez FJ – PersonEntity: Name: NameFull: Leiva M – PersonEntity: Name: NameFull: Cetina-Pérez LDC – PersonEntity: Name: NameFull: Varga S – PersonEntity: Name: NameFull: Molina Alavez A – PersonEntity: Name: NameFull: Alarcon-Rozas AE – PersonEntity: Name: NameFull: Valdiviezo N – PersonEntity: Name: NameFull: Acevedo C – PersonEntity: Name: NameFull: Figueroa A – PersonEntity: Name: NameFull: Santini A – PersonEntity: Name: NameFull: Vera L – PersonEntity: Name: NameFull: Rey F – PersonEntity: Name: NameFull: Kahán Z – PersonEntity: Name: NameFull: Galaz P – PersonEntity: Name: NameFull: Meléndez Mier G – PersonEntity: Name: NameFull: Wu X – PersonEntity: Name: NameFull: Mandai M – PersonEntity: Name: NameFull: Shapira-Frommer R – PersonEntity: Name: NameFull: Estevez-Diz MDP – PersonEntity: Name: NameFull: Limaye S – PersonEntity: Name: NameFull: Xin W – PersonEntity: Name: NameFull: Dry H – PersonEntity: Name: NameFull: Broggi MAS – PersonEntity: Name: NameFull: Yuan DY – PersonEntity: Name: NameFull: Stewart RA – PersonEntity: Name: NameFull: Monk BJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1569-8041 Numbering: – Type: volume Value: 36 – Type: issue Value: 9 Titles: – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology Type: main |
| ResultId | 1 |
